Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

COVID-19, Lockdown Affect Trials in India But Coping Efforts In Hand

Mar 31 2020

• By Anju Ghangurde

Clinical trial — Indian Trials Segment Faces Challenges Amid Coronavirus Pandemic • Source: Shutterstock

Related Content

UK MHRA: COVID-19 To Spark Rise In Clinical Trial-Related Deviations

Mar 12 2020

EU Urges Sponsors To Assess COVID-19 Impact Before Starting New Trials

Mar 23 2020

Lilly, Galapagos Put Some Trials On Hold Due To Coronavirus Concerns

Mar 24 2020

BMS Outlines Clinical Trial Disruptions, Reassures Supply Chain Secure

Mar 25 2020

Related Companies

Amgen, Inc.

Eli Lilly and Company

Galapagos NV

Bristol Myers Squibb Company

Additional Topics

India Asia Pacific Research & Development Coronavirus COVID-19 Clinical Trials BioPharmaceutical

More from R&D

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window